Literature DB >> 12225890

Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity.

Jonathan Kipnis1, Tal Mizrahi, Eti Yoles, Avraham Ben-Nun, Michal Schwartz, Auraham Ben-Nur.   

Abstract

Myelin-specific encephalitogenic T cells, when passively transferred into rats or mice, cause an experimental autoimmune disease. Previous studies by our group have shown that (a) the same cells also significantly reduce post-traumatic degeneration in these animals after injury to the central nervous system, (b) this beneficial autoimmunity is a physiological response, and (c) animals differ in their ability to resist injurious conditions, and the ability to resist post-traumatic degeneration correlates with resistance to the development of an autoimmune disease. Here we show that optic nerve neurons in both resistant and susceptible rat strains can be protected from secondary degeneration after crush injury by immunization with myelin basic protein emulsified in complete or incomplete Freund's adjuvant. We provide evidence that potentially destructive autoimmunity (causing autoimmune disease) and beneficial autoimmunity (causing improved neuronal survival) both result from activity of the same myelin-specific, proinflammatory Th1 cells. We further show that following passive transfer of such Th1 cells, the expression of their beneficial potential depends on the activity of an additional T cell (CD4(+)) population. By identifying the additional cellular component of autoimmune neuroprotection, we may be able to take meaningful steps toward achieving neuroprotection without risk of accompanying autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225890     DOI: 10.1016/s0165-5728(02)00219-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  23 in total

1.  Immunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary.

Authors:  John Hallenbeck; Gregory Del Zoppo; Tom Jacobs; Antoine Hakim; Stephen Goldman; Ursula Utz; Ahmed Hasan
Journal:  Stroke       Date:  2006-11-02       Impact factor: 7.914

Review 2.  Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

Authors:  Dustin J Donnelly; Phillip G Popovich
Journal:  Exp Neurol       Date:  2007-06-30       Impact factor: 5.330

3.  Statins, regulatory T cells and amyotrophic lateral sclerosis.

Authors:  Mark R Goldstein; Luca Mascitelli; Francesca Pezzetta
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 4.  Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.

Authors:  D P Ankeny; P G Popovich
Journal:  Neuroscience       Date:  2008-07-04       Impact factor: 3.590

5.  Regulatory T cells in CNS injury: the simple, the complex and the confused.

Authors:  James T Walsh; Jonathan Kipnis
Journal:  Trends Mol Med       Date:  2011-07-07       Impact factor: 11.951

6.  Brain antigen-reactive CD4+ T cells are sufficient to support learning behavior in mice with limited T cell repertoire.

Authors:  Ali Radjavi; Igor Smirnov; Jonathan Kipnis
Journal:  Brain Behav Immun       Date:  2013-09-05       Impact factor: 7.217

Review 7.  Autoimmunity as the body's defense mechanism against the enemy within: Development of therapeutic vaccines for neurodegenerative disorders.

Authors:  Michal Schwartz
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

8.  Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury.

Authors:  Yaniv Ziv; Hila Avidan; Stefano Pluchino; Gianvito Martino; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-22       Impact factor: 11.205

9.  Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury.

Authors:  T Bucky Jones; Ronald P Hart; Phillip G Popovich
Journal:  J Neurosci       Date:  2005-07-13       Impact factor: 6.167

10.  Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia.

Authors:  Jonathan Kipnis; Hila Avidan; Rachel R Caspi; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.